Abstract

Recently, a growing interest has been seen in the development of T1–T2 dual-mode probes that can simultaneously enhance contrast on T1- and T2-weighted images. A common strategy is to integrate T1 and T2 components in a decoupled manner into a nanoscale particle. This approach, however, often requires a multi-step synthesis and delicate nanoengineering, which may potentially affect the production and wide application of the probes. We herein report the facile synthesis of a 50-nm nanoscale metal–organic framework (NMOF) comprising gadolinium (Gd3+) and europium (Eu3+) as metallic nodes. These nanoparticles can be prepared in large quantities and can be easily coated with a layer of silica. The yielded Eu,Gd-NMOF@SiO2 nanoparticles are less toxic, highly fluorescent, and afford high longitudinal (38 mM−1s−1) and transversal (222 mM−1s−1) relaxivities on a 7 T magnet. The nanoparticles were conjugated with c(RGDyK), a tumor-targeting peptide sequence, which has a high binding affinity toward integrin αvβ3. Eu,Gd-NMOF@SiO2 nanoparticles, when intratumorally or intravenously injected, induce simultaneous signal enhancement and signal attenuation on T1-and T2-weighted images, respectively. These results suggest great potential of the NMOFs as a novel T1–T2 dual-mode contrast agent.

Highlights

  • Magnetic resonance imaging (MRI) is one of the most widely used diagnostic tools in clinics

  • Synthesis and Characterization of Eu,Gd-nanoscale metal– organic framework (NMOF) Eu,Gd-NMOFs were synthesized by mixing H2IPA, Gd(NO3)3, Eu(NO3)3, HMTA and PVP in a mixed solution containing DMF and water, and the solution was heating at 100°C

  • Eu,Gd-NMOFs synthesized using this method were immediately degraded in water, which is a potential problem for bioapplications

Read more

Summary

Introduction

Magnetic resonance imaging (MRI) is one of the most widely used diagnostic tools in clinics. Contrast agents, often in the form of paramagnetic compounds or superparamagnetic nanoparticles, are administered before or during an MRI scan [3,4,5]. These magnetic agents alter local magnetic environments, inducing shortened longitudinal relaxation times (T1) and transverse relaxation times (T2). The most commonly used T1 agents are gadolinium (Gd) complexes [6] and those for T2 imaging are iron oxide nanoparticles [7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call